Ergoteles’s HOOKIPA Pharma HOOK Stock Holding History

Ergoteles’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,350	Closed	-$22K	–	1719
2022 Q2	$22K	Buy	+1,350	New	+$22.3K	﹤0.01%	1581

Other funds holding HOOK

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ergoteles's HOOK Position: Q3 2022 in Review

Ergoteles sold out of HOOKIPA Pharma (HOOK) in Q3 2022, closing a stake of 1,350 shares — an estimated $22K sold.

Ergoteles first reported a position in HOOK in Q2 2022 and held it in 1 quarter. The position peaked at $22K in Q2 2022. 54 funds tracked by Wall St. Rank hold HOOK as of Q3 2022.

Ergoteles reported no remaining HOOKIPA Pharma position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 1,350 HOOKIPA Pharma shares in Q3 2022, an estimated $22K.
Ergoteles first reported a position in HOOKIPA Pharma in Q2 2022 and held it in 1 quarter.
Ergoteles's HOOKIPA Pharma position peaked at $22K in Q2 2022.
54 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.